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Abstract
Background: Chromosomal region 7q21.3 comprises approximately 5.2 mega base pairs that include genes DLX5/6,
SHFM1, and DYNC1I1 associated with split hand/split foot malformation 1. So far, there are reports of eight families
with deletion of DYNC1I1 and preserved DLX5/6 associated with ectrodactyly. From these families, only three
patients did not present ectrodactyly and, unlike our patient, no other cases have been described as having
craniofacial dysmorphology, mitral valve prolapse, kyphoscoliosis, inguinal herniae, or personality disorder. There is
no designation described in the literature for patients with syndromic manifestations without ectrodactyly, which
hinders diagnosis.
Case presentation: We report the case of a 44-year-old mestizo (combined European and Amerindian descent)
man with a 3191 kilo base pairs deletion and International System for Human Cytogenetic Nomenclature array
7q21.3 (93,389,222-96,579,845)x1. Clinical manifestations included micrognathia, retrognathia, wormian bones,
auditory canal stenosis, depressed nasal bridge, epicanthal fold, fullness of upper eyelid, long philtrum, low-set ears,
sensorineural hearing loss, kyphoscoliosis, bilateral inguinal herniae, mild mitral valve prolapse, and paranoid
personality disorder. His isolated DNA was analyzed using a CytoScan HD Microarray system. Chromosome Analysis
Suite software was utilized for the microarray analysis. All copy number changes were determined using the human
genome build 19 (hg19/NCBI build 37).
Conclusions: Cases of deletions within chromosome 7q21.3 that include the split hand/split foot malformation 1
region represent a diagnostic challenge when not presenting ectrodactyly despite being syndromic. Due to the
heterogeneity of the region, a better method to group and classify these patients is needed to facilitate their
clinical diagnosis. For this purpose, we suggest that patients with 7q21.3 deletion including DYNC1I1 and preserved
DLX5/6 without ectrodactyly, accompanied by craniofacial dysmorphology, personality disorder, hearing loss,
musculoskeletal disorder, inguinal herniae and/or mitral valve prolapse be referred to by the eponym Ramos–Martínez
syndrome.
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Background
Chromosome 7 encompasses approximately 158 mega base
pairs (Mb) and 1917 genetic structures [1]. More than 360
diseases are associated to genes that reside within this
chromosome [1]. The identification of the genes for cystic
fibrosis (cystic fibrosis transmembrane conductance regula-
tor, CFTR; Mendelian Inheritance in Man, MIM 602421)
and erythropoietin (EPO; MIM 133170), as well as gene
families such as the T-cell receptor gene family and the
homeobox A gene family have made chromosome 7 a focus
of interest for human genetics research.
Within this chromosome is region 7q21.3 which com-
prises approximately 5.2 Mb [2]. Among the most im-
portant disorders found in this region are Ehlers–Danlos
syndrome type VIIB (MIM 130060), osteogenesis imper-
fecta types II to IV (MIM 166210, 259420, 166220),
neonatal-onset type II citrullinemia (MIM 605814), and
split hand/split foot malformation 1 (SHFM1; MIM
183600). Aberrations in this band are characterized by
wide heterogeneity and variable expression that repre-
sent a challenge for clinical diagnosis.
The genes within the SHFM1 region participate in
proper limb development. These include distal-less
homeobox 5 (DLX5; MIM 600028), distal-less homeobox
6 (DLX6; MIM 600030), deleted in split hand/split foot
malformation 1 region (SHFM1; MIM 601285), and dy-
nein cytoplasmic 1 intermediate chain 1 (DYNC1I1;
MIM 603772) through its exonic enhancers (eExons) 15
and 17. So far, there are reports of eight families with de-
letion of DYNC1I1 and preserved DLX5/6 associated
with ectrodactyly, the main manifestation of the SHFM1
syndrome [3]. We report a case that involves a deletion
of 3 Mb in chromosome 7q21.3 region including
DYNC1I1 with preserved DLX5/6 without ectrodactyly
accompanied by craniofacial dysmorphology, personality
disorder, hearing loss, musculoskeletal manifestations,
bilateral inguinal herniae, and mitral valve prolapse.
Case presentation
We report the case of a 44-year-old mestizo (combined
European and Amerindian descent) man born to non-
consanguineous parents. He is the first of two children con-
ceived by a 25-year-old mother and a 34-year-old father; he
has no relevant prenatal history and no known family his-
tory of congenital malformations, although his father was
diagnosed with schizophrenia. There was no known expos-
ure to teratogenic drugs, infections, or radiation. He was
born at 41-week gestation by normal vaginal delivery.
He underwent multiple reconstructive surgeries 15 years
prior to our evaluation, where mandibular hypoplasia and
prominent low-set ears were corrected. Photographs from
childhood showed epicanthal fold, fullness of upper eyelid,
depressed nasal bridge, anteverted nares, long philtrum,
malocclusion, micrognathia, retrognathia, full cheeks, and
prominent low-set ears.
His first physical evaluation at our institution was per-
formed at age 42. Clinical findings included male pattern
baldness and black hair with multiple strands of gray
hair, stenosis of the cartilaginous portion of his external
auditory canal and low-set ears, long uvula, enlarged
thyroid gland, mitral murmur, kyphoscoliosis, bilateral
inguinal herniae, erythematous and scaly lesions of his
feet consistent with tinea pedis, as well as discolored
yellow-green nails consistent with onychomycosis.
Echocardiography revealed impaired relaxation grade
1 and mild prolapse of the anterior leaflet of his mitral
valve. Audiometry reported bilateral sensorineural hear-
ing loss; the test was limited by the presence of cerumen
impaction mainly in his right auditory canal. Computed
tomography revealed surgical evidence in inferior maxil-
lary bone, showing signs of microgenia, retrognathia, and
a slight abnormality of dental occlusion. His infratentorial
and supratentorial brain parenchyma was of normal dens-
ity. Wormian bones were identified in his occipital cranial
region (Fig. 1). The shape of his skull had a mild dolicho-
cephalic configuration. His right ear presented cerumen
impaction of 16.0×10.5 mm. His middle and inner ear
structures were without abnormalities.
A Minnesota Multiphasic Personality Inventory-2
(MMPI-2) [4] showed an elevated psychological profile on
the scales of hysteria, hypochondriasis, and paranoia; the
patient appeared to be socially balanced, extraverted, and
open to new experiences, as well as spontaneous, control-
ling, excessively rational, rigid, egocentric, defensively
paranoid, power-oriented, interiorly distrustful, suspicious,
hostile, and extremely avoidant of criticism. In general, he
was very calm, but prone to periods of anxiety, tension,
and somatic symptoms. The results of a House-Tree-
Person [5] test concurred with the previously described
findings. Based on the evaluations, a paranoid personality
disorder was established. An intellectual quotient of 90, a
verbal intellectual quotient of 92, and a performance intel-
lectual quotient of 84 were reported.
Additional laboratory analyses showed: thyroid function
test results of total and free triiodothyronine (T3), total
and free thyroxine (T4), and thyroid-stimulating hormone
(TSH) to be within normal ranges; a slight increase in
total cholesterol levels with a value of 222 mg/dl; high-
density lipoprotein (HDL) of 43 mg/dl and low-density
lipoprotein (LDL) of 128 mg/dl; elevated triglycerides with
a value of 234 mg/dl; no electrolyte abnormalities. His
levels of glycemia, creatinine, transaminases, bilirubin, and
testosterone were within normal ranges.
A total of 15 cells in metaphase were analyzed through
conventional G-band karyotyping, reporting normal
46,XY. Due to the patient’s language characteristics as
perceived by the examiner (verbiage), the affinity for
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music showed by the patient (multi-instrumentalist),
complemented with the craniofacial dysmorphology,
Williams–Beuren syndrome (MIM 194050) was sus-
pected. A score of 8 was obtained when the Williams
syndrome scoring table, which was presented at the
1994 Williams Syndrome Association Convention in
San Diego, California, was applied; if the score ≥3, fluor-
escence in situ hybridization (FISH) studies should be
considered [6].
A 7 ml whole blood sample was extracted for analysis.
To rule out aberrations related to the Williams–Beuren
syndrome, a FISH was performed using a probe specific
for the elastin gene (ELN; MIM 130160) in the Williams
syndrome critical region on chromosome 7. In an indi-
vidual who does not have the deletion, four signals will
be detected, two signals on each chromosome 7. The
signal at 7q11.23 is specific for the elastin gene, while
the signal at 7q36 is the D7S427 chromosome 7 control
probe which facilitates identification of the chromosome
7 homologs. In this study, 25 of 25 metaphase spreads
and 65 of 66 interphase nuclei examined produced four
signals indicating that there was no deletion in this re-
gion [see Additional file 1].
FISH analysis does not cover all genes involved in
Williams–Beuren syndrome within region 7q11.23.
Therefore, a whole genome single nucleotide poly-
morphism (SNP) array was performed. A second blood
sample was extracted and DNA was analyzed using a
CytoScan HD Microarray system (Affymetrix). This plat-
form consists of 2.67 million markers (comprising ~1.9
million non-polymorphic copy number probes and
~750,000 SNP probes) at an average spacing of 1 probe
every 800 base pairs (bp) throughout the entire human
genome. This test compares the patient’s sample with
control samples from the HapMap set of 270 individuals,
and identifies genomic copy number variations and loss
of heterozygosity regions. Chromosome Analysis Suite
(ChAS) was utilized for the analysis of this microarray.
SNP genotyping on this platform has the enhanced ability
to identify long contiguous stretches of homozygosity
(LCSH) and uniparental disomy; however, this assay cannot
detect polyploidy, balanced rearrangements (for example,
inversions and balanced chromosomal translocations),
point mutations, and most mosaic conditions. All copy
number changes were determined using the human
genome build 19 (hg19/NCBI build 37).
Microarray CytoScan revealed 3191 kilo base pairs (kb)
in a different region of chromosome 7 with International
System for Human Cytogenetic Nomenclature (ISCN)
array (hg19) 7q21.3 (93,389,222-96,579,845)x1. This dele-
tion included SHFM1 syndrome region and 31 genes, of
which 17 have Online Mendelian Inheritance in Man
(OMIM) entries. The OMIM genes within this region are
TFPI2 (MIM 600033), GNGT1 (MIM 189970), GNG11
(MIM 604390), BET1 (MIM 605456), collagen type 1
alpha-2 (COL1A2; MIM 120160), CASD1 (MIM 611686),
sarcoglycan epsilon (SGCE; MIM 604149), PEG10 (MIM
609810), PPP1R9A (MIM 602468), PON1 (MIM 168820),
PON3 (MIM 602720), PON2 (MIM 602447), ASB4 (MIM
605761), PDK4 (MIM 602527), DYNC1I1, solute carrier
family 25 (citrin) member 13 (SLC25A13; MIM 603859),
and SHFM1. The deletion did not include genes DLX5/6
[see Additional file 2].
Five maternal family members who showed mild man-
dibular hypoplasia and epicanthal fold were also ana-
lyzed. Microarray CytoScan did not report abnormalities
in copy number of known or potential significance for
the regions included on the chip. No cytogenetic ana-
lyses were performed on the patrilineal side of the pa-
tient. The father died before the patient was identified,
and there were no available family members from the
patrilineal side for genetic study.
Fig. 1 Three-dimensional reconstruction of the computed tomography of the patient’s head. a Lateral view shows surgical evidence in inferior maxillary
bone, showing signs of microgenia, retrognathia, and a slight abnormality of dental occlusion. b Posterior view shows wormian bones in his
occipital region
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Discussion
We described a patient with craniofacial dysmorphology
and paranoid personality disorder with a 3 Mb deletion
in chromosome 7q21.3. In this case, a deletion of
DYNC1I1 gene with preserved DLX5/6 without ectro-
dactyly was reported. In addition, he presented musculo-
skeletal disorder, bilateral inguinal herniae, mitral
prolapse, and auditory canal stenosis.
There are reports of eight families with deletion of
DYNC1I1 and preserved DLX5/6 associated with ectro-
dactyly, but with decreased penetrance [3]. Delgado and
Velinov reported the case of a family (the father and
three of his sons) with a 1 Mb deletion associated to
various degrees of intellectual disability; only two of the
male siblings had ectrodactyly [3]. However, echocardi-
ography was normal in all cases and no craniofacial
dysmorphology was described. Tayebi et al. described
four families with deletions of 167 kb (family 1), 510 kb
(family 2), 205 kb (family 3), and 169 kb (family 4) [7].
Families 1, 3, and 4 presented SHFM1 without hearing
loss. Family 2 presented SHFM1 with hearing loss. Un-
like our case, none of the families reported craniofacial
dysmorphology. Mitral valve prolapse, personality dis-
order, neurological or motor abnormalities were not re-
ported. Rattanasopha et al. reported the case of a family
of 10 members with a 103 kb deletion, of which eight
presented SHFM1 with variable severity and two did not
present ectrodactyly [8]. Unlike our patient, none of the
cases reported ear abnormalities. The two family mem-
bers described by Rattanasopha without SHFM1 did not
present any other associated abnormality. Lango Allen et
al. reported the case of a family of two members with a
106 kb deletion with ectrodactyly, in which hearing loss
was the only associated manifestation described [9].
Kouwenhoven et al. described a patient with 880 kb de-
letion with non-syndromic SHFM1 [10]. Genomic
locations and phenotypes for the nine families, including
the present case report, are shown in Table 1.
The deletion of COL1A2 gene might be the primary
cause for the development of mitral valve prolapse iden-
tified in our patient. However, as described by Hirschfeld
et al., abnormalities of the thoracic skeleton, such as
scoliosis, are associated with the development of secondary
mitral prolapse [11]. Mutations of the COL1A2 gene have
been related to bilateral inguinal herniae and wormian
bones in Ehlers–Danlos syndrome type VIIB [12, 13].
The deletion of SGCE gene has been related with psych-
osis and cognitive impairment, and might be responsible
for the paranoid personality disorder of our patient. Dale
et al. reported the case of a family with a 0.17 Mb deletion
that involved 90 % of SGCE, describing it as a risk factor
for psychiatric diseases [14]. It is noteworthy that the
father of the index case in this report was diagnosed with
paranoid schizophrenia, with a high incidence of psychosis
in the extended family. Genetic analyses of the patrilineal
side of our patient would have been convenient because
his father was diagnosed with schizophrenia.
DYNC1I1 gene contains eExons 15 and 17, which inter-
act with DLX5 and DLX6 in limb development [15]. Aber-
rations that involve these enhancers have been associated
with SHFM1, hearing loss, craniofacial malformations,
and intellectual disability [15, 16]. Our patient did not
present ectrodactyly, even though this gene was included
in the deletion. This could be explained by the incomplete
penetrance described in this region [3]. In addition, Hong
et al. described the existence of secondary enhancers
(shadow enhancers) that explain why deletions of well-
defined enhancers sometimes do not produce expected
phenotypes, a mechanism that could account for the nor-
mal limb development of our patient [17].
SLC25A13 contains the intragenic enhancer hs1642,
which has been associated with hearing loss [7]. The
Table 1 Genomic locations and phenotypes of nine families associated with deletion of DYNC1I1 and preserved DLX5/6
Family (authors and Reference number) Genomic location (hg19) Size of deletion (kb) Phenotype
This case report chr7: 93,389,222-96,579,845 3191 Craniofacial dysmorphology, personality disorder, hearing
loss, musculoskeletal disorder, inguinal herniae, mitral
valve prolapse, without ectrodactyly
Tayebi et al. [7] family 1 chr7:95,615,187-95,783,313 167 SHFM
Tayebi et al. [7] family 2 chr7:95,624,825-96,135,521 510 SHFM, hearing loss
Tayebi et al. [7] family 3 chr7: 95,667,046-95,872,044 205 SHFM
Tayebi et al. [7] family 4 chr7:95,693,341-95,862,369 169 SHFM
Delgado and Velinov [3] chr7:94,769,383-95,801,045 1000 Two members Intellectual disability, SHFM
Two members Intellectual disability, without SHFM
Rattanasopha et al. [8] N/A 103 Eight members SHFM
Two members No abnormalities
Lango Allen et al. [9] N/A 106 SHFM, hearing loss
Kouwenhoven et al. [10] N/A 880 Non-syndromic SHFM
N/A not available, SHFM split hand/split foot malformation
Ramos-Zaldívar et al. Journal of Medical Case Reports  (2016) 10:156 Page 4 of 7
deletion of this gene could explain the sensorineural
hearing loss reported in the audiometry of our patient.
However, the auditory canal stenosis and the tendency
to accumulate cerumen are other factors that contribute
to the hearing loss of our patient.
The SHFM1 gene has been associated with multiple
craniofacial malformations, such as micrognathia, retro-
gnathia, auditory canal stenosis, low-set ears, and de-
pressed nasal bridge [16, 18–20]. The craniofacial
dysmorphology of our patient could be explained by the
deletion of this gene.
Conclusions
Among the families reported so far with DYNC1I1 dele-
tion and preserved DLX5/6, the 3191 kb deletion of our
patient is the most extensive. From the other eight fam-
ilies, only three patients did not present ectrodactyly and
no cases described craniofacial dysmorphology, mitral
valve prolapse, kyphoscoliosis, inguinal herniae, or per-
sonality disorder. These phenotypical differences might
be caused by the deletion of more genes in our patient.
Cases of deletions within chromosome 7q21.3 that in-
clude the SHFM1 region represent a diagnostic challenge
when not presenting with ectrodactyly, despite being syn-
dromic. Due to the heterogeneity of the region, a better
method to group and classify these patients is needed to
facilitate their clinical diagnosis. For this purpose, we sug-
gest that patients with 7q21.3 deletion including DYNC1I1
and preserved DLX5/6 without ectrodactyly, accompanied
by craniofacial dysmorphology, personality disorder, hear-
ing loss, musculoskeletal disorder, inguinal herniae and/or
mitral valve prolapse be referred to by the eponym Ra-
mos–Martínez syndrome.
Patient’s perspective
This is an encouraging moment; a special Sunday when
I face the possibility of accomplishing something I
longed for all my life. As I listen to Chopin’s preludes, I
feel immensely grateful because life has given me this
experience; God has been very loving and caring with
me. This gratitude extends to this prestigious journal,
the Journal of Medical Case Reports, which gives me the
blessed opportunity to express my perspective as a pa-
tient. In my view, this is very admirable since years ago
journals only published the medical report without re-
gard for what the patient felt or wanted to say. Whatever
the reason for the decision made by the journal, I thank
you deeply for taking the time to read these simple lines.
This only confirms my admiration for all your excellent
work and distinguished social projection in such a
complicated, but no less interesting, area as is medicine
with all of its wonderful and useful contributions to
humanity.
Ever since I was born, the love of my family made
them strive to provide me with the best conditions ac-
cording to their means. They did so by placing me in the
hands of the best doctors of my country, Honduras, in
Central America. So without knowing exactly what was
happening, and almost by inertia, they sought the help
of many different specialists: pediatricians, otolaryngolo-
gists, and others. Unfortunately, they could never give
me a definitive diagnosis. That taught me the discipline
of taking care of my own health. Later, from the age of
17 onwards, I personally searched for professional help
due to the discomforts I felt; more specifically, I con-
sulted a plastic surgeon, a cardiologist, a dermatologist,
a gastroenterologist, an orthopedist, and general practi-
tioners. With your permission, I will use an analogy to
explain the symptoms I have experienced:
Long ago Copernicus made public the reality, now
proven by science, that our planet Earth revolved around
the Sun and not the other way around. Many things that
were not previously accepted have been uncovered by
science and we are still shrouded in the astonishing mys-
tery of life since the Big Bang started to expand our uni-
verse. I have noticed in time that the world does not
revolve around my existence, but it is my being that de-
pends on the laws of life (just as I am). What am I?
Nothing more than one of the countless forms of life
that constitutes part of this vast and deep universe, like
some kind of nanocosmos (DNA). Some time passed be-
fore I began to suspect the true nature of my genetics. I
was born almost like everyone else, but without knowing
there was a small flaw in my genetics. God using those
angelical beings, as I like to call doctors and nurses, was
helping me to realize what was happening to me. It was
evident that I was born with low-set ears, a small chin,
and other features would become more noticeable in
time. The love of my blessed parents and my phenom-
enal family raised me in an environment full of joy, of
music, of reunion, of prayer, and of fraternity. Amid all
these symptoms, using the analogy above, there was still
an interesting and sensible path to travel.
I noticed that the visits to the doctors became more fre-
quent and sensed that beyond a general medical examin-
ation something was going on, but I could not explain it.
At home, I was always treated as a normal person, a child
like everyone else. It was not until the fifth year in school
that I began to be a victim of bullying. This was like a kind
of tunnel in my life, the years went by, and I even lost
three years of high school because I did not know how to
handle these emotions. When I started my adolescence, I
noticed that my open bite was more apparent, even the
shape of my skull bulging from behind, excessive acne that
once required emergency surgery, and suffering from four
fissures in my feet, stomach aches, anxiety, frequent head-
aches, and a level of depression that only believing in God
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and feeling loved by my family and my friends gave me
the hope and strength to carry on.
It was not until several years later that, realizing that
there was a research team at the Universidad Católica
de Honduras, I sought professional help that was imme-
diately and gladly accepted, leading to a series of general
and specific tests. On the one hand I felt normal because
I had already been through hospitals and other medical
centers; on the other hand, I felt very optimistic because
it meant the possibility of really discovering who I was
genetically. I did not suffer any discomfort during these
tests, just a feeling of anxiety while staying still during
tomography, and some weakness during the extraction
of blood samples. However, I felt that God was with me
more and more because we were working with the sci-
entific method to help me elucidate my case.
At my 44 years of age I still feel like an adolescent and
want to experience life to its fullest. I try to enjoy every-
thing that happens to me. I still periodically feel low
blood pressure and deafness. I get tired more easily, with
pain when I walk a lot and excel myself due to some in-
guinal hernias. I see flies or black spots, and I also feel
anxiety, but with a little more self-control. However,
these are small things compared to the improvement I
have felt knowing the result of my genetic study. Now I
see a little more clearly and know myself much better. I
love to always enjoy my family, my mother, my sister,
my little nieces and nephew, and others, including my
pets, my time alone by myself, my friends, my work en-
vironment, and anywhere I go. I have a vital strength; I
like to walk a lot, observe life, and think that even
though I am not much different from what I was before
starting the genetic test now I have a greater awareness
of my life. There are endless things that I would like to
share and will finish with this poem:
I will never be able to explain it humanly: God exists;
my chromosome 7 demonstrates it; rain of pure love;
mysterious DNA; missing link whose mercy finds and
restores; I have wandered like the people of Israel for
44 years and the uncreated light; immortal God; reveals
His mercy in the unusual. Like a gipsy I went from doc-
tor to doctor; from hospital to operating room; he shall
not live; was dictum of science when they saw my birth;
but God decided otherwise; before seeing Promised
Land; he shall overcome great challenges; then he will
know who he is; and there came His embrace of light
during my grief; I suffered without knowing that in pain
God peered, hidden and suspicious, for his plan was un-
foreseen; He concealed 17 genes that would shout with
time; all his heart will sigh life; and I survived; and He
gave me the musical angel; I will give him my grace and
he will live. And I was invited to the school of pain; only
that with every blow his love was more abundant; and I
sang to the rays of the silver moon; and I wrote to the
deserts where He took me; and He put before me an
oasis of peace and reflection; and I acted with the script
of my own story; everything and everyone has Christ
sent to call me to the permanent celebration inside my
soul; musicalizes with notes of Andromeda’s perfume;
even what I do not understand; everything is a blessing;
and as the people of Israel had their Messiah; that gen-
tiles at their compass would receive; in the same way I
received that good news; God knows what is best; like
everyone I have human flaws and miseries, maybe more
than others; but well above my clay and molecules, I
came to tell the world that God is love and that it is pos-
sible to be happy; even within my syndrome; happiness
is you; because God lives within you; so many things I
would want to write; but my clumsy inspiration leaves
me with nothing more; it is so great the desire of saying
a new language; the one God made when creating the
Big Bang; that I would never end even at a rate of light
speed to the infinite power. Oh heart that has received
countless emotions; go ahead without faltering; more
than trigonometric formulas, laboratories, and genetics;
I put in the hands of God and science, what is left to
live, in harmony.
Additional files
Additional file 1: Fluorescence in situ hybridization. Fluorescence in situ
hybridization was performed using a probe specific for the elastin gene
(ELN) in the Williams syndrome critical region on chromosome 7.
(PDF 12 kb)
Additional file 2: Microarray CytoScan. DNA analysis using a CytoScan
HD Microarray system (Affymetrix). (PDF 20 kb)
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